Laurence Jay Korn, Director at PDL BIOPHARMA, INC. (PDLI), sold 18,626 shares at $22.81 ($425K) on 2006-11-29, disclosed to the SEC on 2006-12-01.
Open-market sale of $425k PDLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.81 | 5,005 | $114K | 26.8% |
| 2 | $22.82 | 1,200 | $27K | 6.4% |
| 3 | $22.84 | 600 | $14K | 3.2% |
| 4 | $22.84 | 10,000 | $228K | 53.7% |
| 5 | $22.85 | 1,821 | $42K | 9.8% |
| Total | $22.83 avg | 18,626 |
| $425K |
| 100% |
| Filing → |
| PDLI | SELL | 2006-03-03 | $789K | — | Filing → |
| PDLI | SELL | 2006-03-02 | $6K | — | Filing → |
| PDLI | SELL | 2006-01-11 | $2.2M | — | Filing → |